These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693 [TBL] [Abstract][Full Text] [Related]
4. Role of Albano D; Bosio G; Giubbini R; Bertagna F Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503 [TBL] [Abstract][Full Text] [Related]
5. The value of 18F-FDG PET/CT in Langerhans cell histiocytosis. An R; Ma X; Wang Y Ann Nucl Med; 2024 Mar; 38(3):238-245. PubMed ID: 38217750 [TBL] [Abstract][Full Text] [Related]
6. Application of Liao F; Luo Z; Huang Z; Xu R; Qi W; Shao M; Lei P; Fan B Contrast Media Mol Imaging; 2022; 2022():8385332. PubMed ID: 36051931 [TBL] [Abstract][Full Text] [Related]
7. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Phillips M; Allen C; Gerson P; McClain K Pediatr Blood Cancer; 2009 Jan; 52(1):97-101. PubMed ID: 18951435 [TBL] [Abstract][Full Text] [Related]
8. The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging Rameh V; Voss S; Bedoya MA; Beaulieu D; Zhang D; Degar BA; Tsai A Pediatr Blood Cancer; 2023 Jan; 70(1):e30057. PubMed ID: 36266951 [TBL] [Abstract][Full Text] [Related]
9. Role of Luo ZH; Lu PX; Qi WL; Liao FX; Jin AF; Zen QY Quant Imaging Med Surg; 2022 Jun; 12(6):3351-3363. PubMed ID: 35655814 [TBL] [Abstract][Full Text] [Related]
10. Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis. Ferrell J; Sharp S; Kumar A; Jordan M; Picarsic J; Nelson A Pediatr Blood Cancer; 2021 Apr; 68(4):e28891. PubMed ID: 33442960 [TBL] [Abstract][Full Text] [Related]
11. Comparison of whole-body DW-MRI with 2-[ Baratto L; Nyalakonda R; Theruvath AJ; Sarrami AH; Hawk KE; Rashidi A; Shen S; States L; Aboian M; Jeng M; Daldrup-Link HE Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1689-1698. PubMed ID: 36717409 [TBL] [Abstract][Full Text] [Related]
12. Preliminary study on the evaluation of Langerhans cell histiocytosis using F-18-fluoro-deoxy-glucose PET/CT. Zhou W; Wu H; Han Y; Wang S; Dong Y; Wang Q Chin Med J (Engl); 2014; 127(13):2458-62. PubMed ID: 24985583 [TBL] [Abstract][Full Text] [Related]
13. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis. Lee HJ; Ahn BC; Lee SW; Lee J Ann Nucl Med; 2012 Nov; 26(9):730-7. PubMed ID: 22797842 [TBL] [Abstract][Full Text] [Related]
14. Dural involvement in central nervous system langerhans cells histiocytosis (LCH) on FDG PET/CT: Case report and review of CNS manifestations of LCH on PET/CT. Eddin AS; McNeely P; Saad Eldine M; Lai L; Shariftabrizi A Radiol Case Rep; 2024 Apr; 19(4):1391-1396. PubMed ID: 38268737 [TBL] [Abstract][Full Text] [Related]
15. 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary thyroid langerhans histiocytosis: A case report and literature review. Long Q; Shaoyan W; Hui W Indian J Nucl Med; 2015; 30(4):328-30. PubMed ID: 26430317 [TBL] [Abstract][Full Text] [Related]
18. Solitary Adult Rib Langerhans Cell Histiocytosis Evaluated by 18F-FDG PET/CT. Wang Q; Yang S; Tang W; Liu H; Chen Y Clin Nucl Med; 2021 Sep; 46(9):756-758. PubMed ID: 33795592 [TBL] [Abstract][Full Text] [Related]
19. 18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations. Agarwal KK; Seth R; Behra A; Jana M; Kumar R Jpn J Radiol; 2016 Apr; 34(4):267-76. PubMed ID: 26759026 [TBL] [Abstract][Full Text] [Related]
20. Niu J; Liang J; Feng Q; Wang M; Wang L; Ge X; Wang X; Ding Z Int J Gen Med; 2021; 14():6251-6259. PubMed ID: 34629891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]